Chylothorax and Cholesterol Pleural Effusion

 

 Buy Article Permissions and Reprints

ABSTRACT

A chylothorax and a cholesterol pleural effusion represent the two forms of lipid effusions encountered. Traditionally, a lipid pleural effusion is characterized by the presence of milky fluid. Although these two effusions often share a similar pleural fluid appearance due to the high lipid concentration, they have major differences in the pathogenesis, clinical presentation, diagnosis, predisposing conditions, and management of these effusions. A chylothorax is defined by the presence of chyle in the pleural space resulting from obstruction or disruption of the thoracic duct or one of its major tributaries. A triglyceride concentration > 110 mg/dL is virtually diagnostic, but the presence of chylomicrons confirms the diagnosis. However, a chylothorax defined by these criteria represents a heterogeneous group of clinical entities. The presence of chylomicrons or triglyceride levels > 110 mg/dL in a pleural effusion should be considered evidence of chyle leakage of indeterminate clinical significance. Many cases of a chylous effusion may be associated with other causes of pleural fluid formation. In the case of an acute or chronic chylothorax due to recent or remote thoracic duct injury, this assessment is essential, as surgical ligation of the thoracic duct is often entertained. In other cases, especially lymphoma or chylous ascites, treatment of the underlying condition is indicated regardless, and the assessment of the response to treatment is a reasonable initial approach. In contrast, a cholesterol effusion is typically the result of long-standing pleurisy with elevated cholesterol levels in the pleural space; however, this paradigm has been challenged. Lung entrapment with thickened parietal and visceral pleural membranes is the typical radiographic findings of a cholesterol effusion. Most cases of cholesterol pleural effusions are attributed to tuberculous or rheumatoid pleurisy. Decortication is the mainstay of treatment for a cholesterol effusion in symptomatic patients with restrictive lung function.

REFERENCES

• 1 Agrawal V, Sahn S A. Lipid pleural effusions.  Am J Med Sci. 2008;  335 16-20
  CrossrefPubMedGoogle Scholar
• 2 Doerr C H, Miller D L, Ryu J H. Chylothorax.  Semin Respir Crit Care Med. 2001;  22 617-626
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Staats B A, Ellefson R D, Budahn L L, Dines D E, Prakash U B, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions.  Mayo Clin Proc. 1980;  55 700-704
  PubMedGoogle Scholar
• 4 Merrigan B A, Winter D C, O'Sullivan G C. Chylothorax.  Br J Surg. 1997;  84 15-20
  CrossrefPubMedGoogle Scholar
• 5 Nair S K, Petko M, Hayward M P. Aetiology and management of chylothorax in adults.  Eur J Cardiothorac Surg. 2007;  32 362-369
  CrossrefPubMedGoogle Scholar
• 6 Zilversmit D B. The composition and structure of lymph chylomicrons in dog, rat, and man.  J Clin Invest. 1965;  44 1610-1622
  CrossrefPubMedGoogle Scholar
• 7 Van Pernis P A. Variations of the thoracic duct.  Surgery. 1949;  26 806-809
  PubMedGoogle Scholar
• 8 McGrath E E, Blades Z, Anderson P B. Chylothorax: aetiology, diagnosis and therapeutic options.  Respir Med. 2010;  104 1-8
  CrossrefPubMedGoogle Scholar
• 9 Valentine V G, Raffin T A. The management of chylothorax.  Chest. 1992;  102 586-591
  CrossrefPubMedGoogle Scholar
• 10 Doerr C H, Allen M S, Nichols III F C, Ryu J H. Etiology of chylothorax in 203 patients.  Mayo Clin Proc. 2005;  80 867-870
  CrossrefPubMedGoogle Scholar
• 11 Fairfax A J, McNabb W R, Spiro S G. Chylothorax: a review of 18 cases.  Thorax. 1986;  41 880-885
  CrossrefPubMedGoogle Scholar
• 12 Bolger C, Walsh T N, Tanner W A, Keeling P, Hennessy T P. Chylothorax after oesophagectomy.  Br J Surg. 1991;  78 587-588
  CrossrefPubMedGoogle Scholar
• 13 Dougenis D, Walker W S, Cameron E W, Walbaum P R. Management of chylothorax complicating extensive esophageal resection.  Surg Gynecol Obstet. 1992;  174 501-506
  PubMedGoogle Scholar
• 14 Orringer M B, Bluett M, Deeb G M. Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy.  Surgery. 1988;  104 720-726
  PubMedGoogle Scholar
• 15 Suemitsu R, Ondo K, Fukuyama S, Ueda H. Late-period-onset chylothorax after a pulmonary resection for lung cancer: a case report.  Ann Thorac Cardiovasc Surg. 2007;  13 345-348
  PubMedGoogle Scholar
• 16 Halldorsson A. Chylothorax after coronary artery bypass grafting.  Int Surg. 2009;  94 119-129
  PubMedGoogle Scholar
• 17 Zaidenstein R, Cohen N, Dishi V, Alon I, Golik A, Modai D. Chylothorax following median sternotomy.  Clin Cardiol. 1996;  19 910-912
  CrossrefPubMedGoogle Scholar
• 18 Ng R S, Kerbavaz R J, Hilsinger Jr R L. Bilateral chylothorax from radical neck dissection.  Otolaryngol Head Neck Surg. 1985;  93 814-817
  PubMedGoogle Scholar
• 19 Han C, Guo L, Wang K J, Zhao J Q. Bilateral chylothorax following neck dissection for thyroid cancer.  Int J Oral Maxillofac Surg. 2009;  38 1119-1122
  CrossrefPubMedGoogle Scholar
• 20 Patel N, Lewandowski R J, Bove M, Nemcek Jr A A, Salem R. Thoracic duct embolization: a new treatment for massive leak after neck dissection.  Laryngoscope. 2008;  118 680-683
  CrossrefPubMedGoogle Scholar
• 21 Busquets J M, Rullan P J, Trinidad-Pinedo J. Bilateral chylothorax after neck dissection.  Otolaryngol Head Neck Surg. 2004;  130 492-495
  CrossrefPubMedGoogle Scholar
• 22 Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter.  J Pediatr. 1998;  132 1064-1066
  PubMedGoogle Scholar
• 23 Silen M L, Weber T R. Management of thoracic duct injury associated with fracture-dislocation of the spine following blunt trauma.  J Trauma. 1995;  39 1185-1187
  CrossrefPubMedGoogle Scholar
• 24 Worthington M G, de Groot M, Gunning A J, von Oppell U O. Isolated thoracic duct injury after penetrating chest trauma.  Ann Thorac Surg. 1995;  60 272-274
  CrossrefPubMedGoogle Scholar
• 25 Cammarata S K, Brush Jr R E, Hyzy R C. Chylothorax after childbirth.  Chest. 1991;  99 1539-1540
  CrossrefPubMedGoogle Scholar
• 26 Agrawal V, Doelken P, Sahn S A. Seat belt-induced chylothorax: a cause of idiopathic chylothorax?.  Chest. 2007;  132 690-692
  CrossrefPubMedGoogle Scholar
• 27 Reilly K M, Tsou E. Bilateral chylothorax: a case report following episodes of stretching.  JAMA. 1975;  233 536-537
  CrossrefPubMedGoogle Scholar
• 28 Parker J M, Torrington K G, Phillips Y Y. Sarcoidosis complicated by chylothorax.  South Med J. 1994;  87 860-862
  CrossrefPubMedGoogle Scholar
• 29 Lengyel R J, Shanley D J. Recurrent chylothorax associated with sarcoidosis.  Hawaii Med J. 1995;  54 817-818
  PubMedGoogle Scholar
• 30 Aberg H, Bah M, Waters A W. Sarcoidosis: complicated by chylothorax.  Minn Med. 1966;  49 1065-1070
  PubMedGoogle Scholar
• 31 Rabie H, Lomp A, Goussard P, Nel E, Cotton M. Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child.  J Trop Pediatr. 2010;  56 355-358
  CrossrefPubMedGoogle Scholar
• 32 Goh K L, Tan H W, Loh T G, Yap S. Chylothorax due to filariasis—a case report.  Singapore Med J. 1986;  27 173-176
  PubMedGoogle Scholar
• 33 Almoosa K F, McCormack F X, Sahn S A. Pleural disease in lymphangioleiomyomatosis.  Clin Chest Med. 2006;  27 355-368
  CrossrefPubMedGoogle Scholar
• 34 Ryu J H, Doerr C H, Fisher S D, Olson E J, Sahn S A. Chylothorax in lymphangioleiomyomatosis.  Chest. 2003;  123 623-627
  CrossrefPubMedGoogle Scholar
• 35 King P A, Ghosh A, Tang M H, Lam S K. Recurrent congenital chylothorax.  Prenat Diagn. 1991;  11 809-811
  CrossrefPubMedGoogle Scholar
• 36 Hillerdal G. Yellow nail syndrome: treatment with octreotide.  Clin Respir J. 2007;  1 120-121
  CrossrefPubMedGoogle Scholar
• 37 Maldonado F, Ryu J H. Yellow nail syndrome.  Curr Opin Pulm Med. 2009;  15 371-375
  CrossrefPubMedGoogle Scholar
• 38 Lee S, Finn L, Sze R W, Perkins J A, Sie K C. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature.  Arch Otolaryngol Head Neck Surg. 2003;  129 1340-1343
  CrossrefPubMedGoogle Scholar
• 39 Goldblatt M, Huggins J T, Doelken P, Gurung P, Sahn S A. Dasatinib-induced pleural effusions: a lymphatic network disorder?.  Am J Med Sci. 2009;  338 414-417
  CrossrefPubMedGoogle Scholar
• 40 Agrawal V, Doelken P, Sahn S A. Pleural fluid analysis in chylous pleural effusion.  Chest. 2008;  133 1436-1441
  CrossrefPubMedGoogle Scholar
• 41 Maldonado F, Hawkins F J, Daniels C E, Doerr C H, Decker P A, Ryu J H. Pleural fluid characteristics of chylothorax.  Mayo Clin Proc. 2009;  84 129-133
  CrossrefPubMedGoogle Scholar
• 42 Al-Zubairy S A, Al-Jazairi A S. Octreotide as a therapeutic option for management of chylothorax.  Ann Pharmacother. 2003;  37 679-682
  CrossrefPubMedGoogle Scholar
• 43 Rimensberger P C, Müller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin.  Ann Thorac Surg. 1998;  66 253-254
  CrossrefPubMedGoogle Scholar
• 44 Mares D C, Mathur P N. Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series.  Chest. 1998;  114 731-735
  CrossrefPubMedGoogle Scholar
• 45 Rizzardi G, Loy M, Marulli G, Rea F. Persistent chylothorax in lymphangioleiomyomatosis treated by intrapleural instillation of povidone.  Eur J Cardiothorac Surg. 2008;  34 214-215
  CrossrefPubMedGoogle Scholar
• 46 Jianjun Q, Song Z, Yin L, Jia Z, Donglei L. Treatment of chylothorax with elemene.  Thorac Cardiovasc Surg. 2008;  56 103-105
  Article in Thieme ConnectPubMedGoogle Scholar
• 47 Cope C. Percutaneous transabdominal embolization of thoracic duct lacerations in animals.  J Vasc Interv Radiol. 1996;  7 725-731
  CrossrefPubMedGoogle Scholar
• 48 Cope C, Salem R, Kaiser L R. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial.  J Vasc Interv Radiol. 1999;  10 1248-1254
  CrossrefPubMedGoogle Scholar
• 49 Cope C. Management of chylothorax via percutaneous embolization.  Curr Opin Pulm Med. 2004;  10 311-314
  CrossrefPubMedGoogle Scholar
• 50 Bybel B, Neumann D R, Kim B Y, Amin K, Rice T. Lymphoscintigraphy using (99m)Tc filtered sulfur colloid in chylothorax: a case report.  J Nucl Med Technol. 2001;  29 30-31
  PubMedGoogle Scholar
• 51 Cerfolio R J, Allen M S, Deschamps C, Trastek V F, Pairolero P C. Postoperative chylothorax.  J Thorac Cardiovasc Surg. 1996;  112 1361-1365, discussion 1365–1366
  CrossrefPubMedGoogle Scholar
• 52 Cerfolio R J. Chylothorax after esophagogastrectomy.  Thorac Surg Clin. 2006;  16 49-52
  CrossrefPubMedGoogle Scholar
• 53 Dougenis D, Walker W S, Cameron E W, Walbaum P R. Management of chylothorax complicating extensive esophageal resection.  Surg Gynecol Obstet. 1992;  174 501-506
  PubMedGoogle Scholar
• 54 Graham D D, McGahren E D, Tribble C G, Daniel T M, Rodgers B M. Use of video-assisted thoracic surgery in the treatment of chylothorax.  Ann Thorac Surg. 1994;  57 1507-1511, discussion 1511–1512
  CrossrefPubMedGoogle Scholar
• 55 Patterson G A, Todd T R, Delarue N C, Ilves R, Pearson F G, Cooper J D. Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula.  Ann Thorac Surg. 1981;  32 44-49
  CrossrefPubMedGoogle Scholar
• 56 Weems B F. Cholesterolhydrothorax.  Am J Med Sci. 1918;  156 20
  CrossrefPubMedGoogle Scholar
• 57 Wrightson J M, Stanton A E, Maskell N A, Davies R J, Lee Y C. Pseudochylothorax without pleural thickening: time to reconsider pathogenesis?.  Chest. 2009;  136 1144-1147
  CrossrefPubMedGoogle Scholar
• 58 Ferguson G C. Cholesterol pleural effusion in rheumatoid lung disease.  Thorax. 1966;  21 577-582
  CrossrefPubMedGoogle Scholar
• 59 Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo F J, Gurrutxaga N. Pseudochylothorax: report of 2 cases and review of the literature.  Medicine (Baltimore). 1999;  78 200-207
  CrossrefPubMedGoogle Scholar
• 60 Coe J E, Aikawa J K. Cholesterol pleural effusion: report of 2 cases studied with isotopic techniques and review of the world literature.  Arch Intern Med. 1961;  108 763-774
  CrossrefPubMedGoogle Scholar
• 61 Hillerdal G. Chyliform (cholesterol) pleural effusion.  Chest. 1985;  88 426-428
  CrossrefPubMedGoogle Scholar
• 62 Hillerdal G. Chylothorax and pseudochylothorax.  Eur Respir J. 1997;  10 1157-1162
  CrossrefPubMedGoogle Scholar
• 63 Hamm H, Pfalzer B, Fabel H. Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis.  Respiration. 1991;  58 294-300
  CrossrefPubMedGoogle Scholar
• 64 Nogueras C, Monteagudo M, Vila M, Cabezuelo A, Mariscal D, Berlanga E. Recent-onset tuberculous pleurisy presenting as pseudochylothorax.  Am J Med. 2002;  113 166-168
  CrossrefPubMedGoogle Scholar
• 65 Sassoon C S, Light R W. Chylothorax and pseudochylothorax.  Clin Chest Med. 1985;  6 163-171
  PubMedGoogle Scholar
• 66 Goldman A, Burford T H. Cholesterol pleural effusion: a report of 3 cases with a cure by decortication.  Dis Chest. 1950;  18 586-594
  CrossrefPubMedGoogle Scholar

J. Terrill HugginsM.D. 

Department of Medicine, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina

96 Jonathan Lucas St., Ste 812-CSB, Charleston, SC 29425

Email: hugginjt@musc.edu